189 related articles for article (PubMed ID: 22886530)
1. miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas.
Shi L; Jiang D; Sun G; Wan Y; Zhang S; Zeng Y; Pan T; Wang Z
J Neurooncol; 2012 Nov; 110(2):155-62. PubMed ID: 22886530
[TBL] [Abstract][Full Text] [Related]
2. Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway.
Saydam O; Shen Y; Würdinger T; Senol O; Boke E; James MF; Tannous BA; Stemmer-Rachamimov AO; Yi M; Stephens RM; Fraefel C; Gusella JF; Krichevsky AM; Breakefield XO
Mol Cell Biol; 2009 Nov; 29(21):5923-40. PubMed ID: 19703993
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-224 targets ERG2 and contributes to malignant progressions of meningioma.
Wang M; Deng X; Ying Q; Jin T; Li M; Liang C
Biochem Biophys Res Commun; 2015 May; 460(2):354-61. PubMed ID: 25783051
[TBL] [Abstract][Full Text] [Related]
4. MiR-34a-3p alters proliferation and apoptosis of meningioma cells
Werner TV; Hart M; Nickels R; Kim YJ; Menger MD; Bohle RM; Keller A; Ludwig N; Meese E
Aging (Albany NY); 2017 Mar; 9(3):932-954. PubMed ID: 28340489
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA Dysregulation in Canine Meningioma: RT-qPCR Analysis of Formalin-Fixed Paraffin-Embedded Samples.
Foiani G; Guelfi G; Mandara MT
J Neuropathol Exp Neurol; 2021 Sep; 80(8):769-775. PubMed ID: 34272938
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-195 Functions as a Tumor Suppressor by Directly Targeting Fatty Acid Synthase in Malignant Meningioma.
Song LR; Li D; Weng JC; Li CB; Wang L; Wu Z; Zhang JT
World Neurosurg; 2020 Apr; 136():e355-e364. PubMed ID: 31927122
[TBL] [Abstract][Full Text] [Related]
7. miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells.
Kliese N; Gobrecht P; Pachow D; Andrae N; Wilisch-Neumann A; Kirches E; Riek-Burchardt M; Angenstein F; Reifenberger G; Riemenschneider MJ; Meese E; Panayotova-Dimitrova D; Gutmann DH; Mawrin C
Oncogene; 2013 Sep; 32(39):4712-20. PubMed ID: 23108408
[TBL] [Abstract][Full Text] [Related]
8. A microRNA expression signature predicts meningioma recurrence.
Zhi F; Zhou G; Wang S; Shi Y; Peng Y; Shao N; Guan W; Qu H; Zhang Y; Wang Q; Yang C; Wang R; Wu S; Xia X; Yang Y
Int J Cancer; 2013 Jan; 132(1):128-36. PubMed ID: 22674195
[TBL] [Abstract][Full Text] [Related]
9. Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression.
Simon M; Park TW; Köster G; Mahlberg R; Hackenbroch M; Boström J; Löning T; Schramm J
J Neurooncol; 2001 Dec; 55(3):149-58. PubMed ID: 11859969
[TBL] [Abstract][Full Text] [Related]
10. Functional significance of S6K overexpression in meningioma progression.
Surace EI; Lusis E; Haipek CA; Gutmann DH
Ann Neurol; 2004 Aug; 56(2):295-8. PubMed ID: 15293284
[TBL] [Abstract][Full Text] [Related]
11. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
12. SNHG1/miR-556-5p/TCF12 feedback loop enhances the tumorigenesis of meningioma through Wnt signaling pathway.
Zhang Y; Yu R; Li Q; Li Y; Xuan T; Cao S; Zheng J
J Cell Biochem; 2020 Feb; 121(2):1880-1889. PubMed ID: 31692066
[TBL] [Abstract][Full Text] [Related]
13. BMP-6 inhibits cell proliferation by targeting microRNA-192 in breast cancer.
Hu F; Meng X; Tong Q; Liang L; Xiang R; Zhu T; Yang S
Biochim Biophys Acta; 2013 Dec; 1832(12):2379-90. PubMed ID: 24012720
[TBL] [Abstract][Full Text] [Related]
14. CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitro.
Bajetto A; Barbieri F; Pattarozzi A; Dorcaratto A; Porcile C; Ravetti JL; Zona G; Spaziante R; Schettini G; Florio T
Neuro Oncol; 2007 Jan; 9(1):3-11. PubMed ID: 17108064
[TBL] [Abstract][Full Text] [Related]
15. Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling.
Mei Y; Du Z; Hu C; Greenwald NF; Abedalthagafi M; Agar NYR; Dunn GP; Bi WL; Santagata S; Dunn IF
Cell Commun Signal; 2017 Sep; 15(1):34. PubMed ID: 28923059
[TBL] [Abstract][Full Text] [Related]
16. miR-200a-mediated suppression of non-muscle heavy chain IIb inhibits meningioma cell migration and tumor growth in vivo.
Senol O; Schaaij-Visser TB; Erkan EP; Dorfer C; Lewandrowski G; Pham TV; Piersma SR; Peerdeman SM; Ströbel T; Tannous B; Saydam N; Slavc I; Knosp E; Jimenez CR; Saydam O
Oncogene; 2015 Apr; 34(14):1790-8. PubMed ID: 24858044
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of the kinase tumor suppressor WNK2 is tumor-type and tumor-grade specific.
Jun P; Hong C; Lal A; Wong JM; McDermott MW; Bollen AW; Plass C; Held WA; Smiraglia DJ; Costello JF
Neuro Oncol; 2009 Aug; 11(4):414-22. PubMed ID: 19001526
[TBL] [Abstract][Full Text] [Related]
18. PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss.
Peyre M; Salaud C; Clermont-Taranchon E; Niwa-Kawakita M; Goutagny S; Mawrin C; Giovannini M; Kalamarides M
Oncotarget; 2015 Oct; 6(32):32713-22. PubMed ID: 26418719
[TBL] [Abstract][Full Text] [Related]
19. miR-675 mediates downregulation of Twist1 and Rb in AFP-secreting hepatocellular carcinoma.
Hernandez JM; Elahi A; Clark CW; Wang J; Humphries LA; Centeno B; Bloom G; Fuchs BC; Yeatman T; Shibata D
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S625-35. PubMed ID: 23864307
[TBL] [Abstract][Full Text] [Related]
20. Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1) dysregulation in human malignant meningiomas.
Liu ZY; Wang JY; Liu HH; Ma XM; Wang CL; Zhang XP; Tao YQ; Lu YC; Liao JC; Hu GH
Oncogene; 2013 Mar; 32(10):1216-22. PubMed ID: 22614009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
